•  
  •  
 

Subject Area

Orthopedic Surgery

Article Type

Original Study

Abstract

Objective To evaluate functional outcomes of the shoulder according to University of California, Los Angeles (UCLA) score after ultrasound-guided subacromial injection of platelet-rich plasma (PRP) versus steroid for management of rotator-cuff tendinopathy. Background Subacromial corticosteroid injection is the treatment of choice for rotator-cuff tendinopathy. More recently, ultrasound-guided subacromial PRP injection for rotator-cuff tendinopathy has been considered as a viable alternative to steroid injection. Patients and methods This was a prospective comparative study. Consecutive patients were placed alternately into group A (PRP) and group B (steroid) in a ratio of 1: 1: group A: 25 patients had been managed by ultrasound-guided subacromial injection of PRP. Group B: 25 patients had been managed by ultrasound-guided subacromial injection with steroid. Results The mean age of group A was 44.88 ± 6.89, and 39.76 ± 10.96 in group B. There were no significant side effects reported in both groups. The mean follow-up duration of group A and group B was 6 months. The mean functional scoring system by UCLA score in group A was 28.36 and 33.00 in group B (P < 0.001). Regarding UCLA functional scoring scale, group A recorded as 30% was good, 70% were poor, while group B revealed as 60% was excellent, 30% were good, and 10% were poor. Conclusion Ultrasound-guided subacromial injection of steroid is favorable over PRP in functional outcome of rotator-cuff tendinopathy regarding UCLA score.

Download

Share

COinS